The chronic spontaneous urticaria treatment market is growing due to increased use of biologic therapies like omalizumab, improved diagnostic screening, and unmet need for chronic itch relief. https://www.datamintelligence.com/research-report/chronic-spontaneous-urticaria-treatment-market